InsidersTradesSigma
Follow the 인바이오 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Chemicals sector, 인바이오 has logged 5 insider filings. Market capitalisation: €21.7bn. The latest transaction was reported on 30 June 2026 (Purchase). Among the most active insiders: 이혁재. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Inbio 是一家专注于化学和材料领域的公司，在 XKRX 市场上市。它致力于开发生物技术领域的创新解决方案。